These antibody fragments could simultaneously bind with both NK cells and ovarian cancer cells, and the IL-15 portion was applied to specifically mediate IL-15 signaling on NK cells when inducing ADCC effects for triggering robust NK expansion. The gene discussed is IL15; the disease is ovarian carcinoma.